With the only "ally" against COVID-19 being vaccines, the scientific community has not found a drug that will prevent patients from getting seriously ill and recover without complications.
Speaking to Sputnik Hellas, Aristotle University of Thessaloniki Professor of Pharmacology Dimitris Kouvelas, reiterated his position that the anti-COVID drug is the monoclonal neutralising antibodies.
As he stressed, these have been approved by the U.S. and the European Medicines Agency.
"Antibodies are a medicine and for fifteen days now they have been licensed by the European Medicines Agency," he said, adding that Greece should get them.
Asked about the serious side effects of the AstraZeneca vaccine that is reported about, he said "didn't anyone think that these vaccines should have no side effects and work?"
"So these are the results of the acceleration.
"These vaccines should be known that their clinical study will be completed by the end of 2023.
"Why are vaccines on the market?
"Because after 2022 there will be no pandemic so we will not be able to sell them."
He said that pandemics "always last a period of time, they do not last a lifetime, otherwise we would still be dying of the Spanish flu."
However, apart from the side effects of AstraZeneca, Kouvelas stressed that the doses by other manufacturers also have side effects.
"The others have similar side effects, different but side-effects and deaths," he said, referring to the deaths of 28 elderly people in Norway who were vaccinated with the Pfizer vaccine.
READ MORE: Greece surpasses 2 million COVID-19 vaccinations.